Trends of influenza vaccination coverage in pregnant women: a ten-year analysis from a French healthcare database.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
03 05 2022
03 05 2022
Historique:
received:
31
08
2021
accepted:
11
03
2022
entrez:
3
5
2022
pubmed:
4
5
2022
medline:
6
5
2022
Statut:
epublish
Résumé
Pregnant women have a high risk of severe influenza, associated with obstetrical complications. The World Health Organization (WHO) has recommended influenza vaccination for all pregnant women since 2012. The vaccination coverage remains low worldwide, and in Europe, due to a lack of proposition from the health care providers, and a high refusal rate from the women. The primary aim of this study was to estimate the influenza vaccination coverage (IVC) in a population of pregnant women in France, and to analyse its evolution from 2009 to 2018. The secondary objective was to describe the vaccinated population and to find determinants associated with the vaccination. This retrospective cohort study is based on the EGB French health care database, a representative sample of the French population containing data from the health insurance system. All pregnant women who delivered medically or spontaneously over the 2009-2018 period were included. In the 2009-2018 period, only 1.2% pregnant women were vaccinated against influenza (n = 875/72,207; 95% CI 1.14-1.30). The IVC slightly increased after the 2012 WHO recommendation, from 0.33 to 1.79% (p < 0.001) but remained extremely low (4.1% in 2018). Women younger than 25 years old had a low coverage (0.6%) whereas women over 35 years old were more likely to get the influenza vaccine (1.7%; OR: 2.82, 95% CI 2.14-3.71). The vaccination behavior was not influenced by multifetal pregnancy or parity, but socio-economically deprived women were less likely to be vaccinated (OR: 0.81, 95% CI: 0.67-0.98). Women with pre-existing medical conditions had an overall higher vaccination rate (2.5%; OR: 2.32, 95% CI: 1.94-2.77). The vaccine was mainly prescribed by family physicians (58%). Influenza vaccination in pregnant women in France remains very low, particularly in younger, healthy women, and measures such as information campaigns towards pregnant women and studies of the knowledge, attitudes, and practices of the health care professionals need to be undertaken to improve the coverage.
Identifiants
pubmed: 35505069
doi: 10.1038/s41598-022-11308-3
pii: 10.1038/s41598-022-11308-3
pmc: PMC9062868
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7153Informations de copyright
© 2022. The Author(s).
Références
Occup Med (Lond). 2017 Jan;67(1):44-51
pubmed: 27821643
PLoS One. 2019 Aug 14;14(8):e0220910
pubmed: 31412058
Obstet Gynecol. 2011 Nov;118(5):1074-1080
pubmed: 22015875
J Hosp Infect. 2016 Oct;94(2):133-42
pubmed: 27546456
Vaccine. 2017 Aug 24;35(36):4811-4816
pubmed: 28818474
Am J Epidemiol. 2020 Nov 2;189(11):1379-1388
pubmed: 32735018
Acta Obstet Gynecol Scand. 2021 Jun;100(6):997-1009
pubmed: 33420724
Vaccine. 2018 Dec 18;36(52):8054-8061
pubmed: 30416018
Rev Med Interne. 2015 Jun;36(6):411-7
pubmed: 25547954
PLoS Med. 2011 May;8(5):e1000441
pubmed: 21655318
Lancet Infect Dis. 2021 Jan;21(1):97-106
pubmed: 33129424
BMC Public Health. 2019 May 2;19(1):487
pubmed: 31046725
Lancet Infect Dis. 2017 Sep;17(9):981-989
pubmed: 28522338
Vaccine. 2020 Jun 2;38(27):4246-4251
pubmed: 32409134
Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76
pubmed: 23210147
Vaccine. 2020 Oct 7;38(43):6766-6776
pubmed: 32868133
Presse Med. 2013 Nov;42(11):1453-60
pubmed: 23683385
N Engl J Med. 2014 Sep 4;371(10):918-31
pubmed: 25184864
Cochrane Database Syst Rev. 2018 Feb 01;2:CD001269
pubmed: 29388196
Am J Obstet Gynecol. 2021 Sep;225(3):303.e1-303.e17
pubmed: 33775692
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Euro Surveill. 2018 Nov;23(48):
pubmed: 30514414
Clin Infect Dis. 2021 Dec 6;73(11):e4296-e4304
pubmed: 32572453
J Intern Med. 2019 Oct;286(4):469-480
pubmed: 31259452
Acta Odontol Scand. 2002 Jun;60(3):136-40
pubmed: 12166905
Vaccine. 2020 Jun 26;38(31):4805-4815
pubmed: 32499068
PLoS One. 2019 Aug 1;14(8):e0220705
pubmed: 31369626
Semin Fetal Neonatal Med. 2006 Oct;11(5):279-95
pubmed: 16784908
N Engl J Med. 2010 Apr 29;362(17):1644-6
pubmed: 20427817
CMAJ. 2012 Apr 3;184(6):645-53
pubmed: 22353593
Gynecol Obstet Fertil. 2012 Apr;40(4):208-12
pubmed: 22154671
Infect Dis (Auckl). 2020 Feb 10;13:1178633720904099
pubmed: 32095076
Cochrane Database Syst Rev. 2015 Jun 09;(6):CD009982
pubmed: 26059051
Vaccine. 2016 Nov 21;34(48):5907-5911
pubmed: 27773474
Eur J Obstet Gynecol Reprod Biol. 2019 Dec;243:36-40
pubmed: 31671289
Presse Med. 2012 Nov;41(11):e568-76
pubmed: 22795870
Vaccine. 2016 Apr 29;34(20):2390-6
pubmed: 27013430
J Obstet Gynaecol Can. 2019 Apr;41(4):479-488
pubmed: 30409569
Pharmacoepidemiol Drug Saf. 2010 Mar;19(3):256-65
pubmed: 20128015
Am J Obstet Gynecol. 2009 Dec;201(6):547-52
pubmed: 19850275
BMC Public Health. 2019 Jul 5;19(1):890
pubmed: 31277611
Vaccine. 2020 Dec 14;38(52):8405-8410
pubmed: 32741669
Sante Publique. 2006 Dec;18(4):513-22
pubmed: 17294755
PLoS One. 2022 Feb 7;17(2):e0263512
pubmed: 35130318
Influenza Other Respir Viruses. 2019 Nov;13(6):582-592
pubmed: 31419068
BMJ. 2013 Aug 23;347:f5061
pubmed: 23974637
BMC Public Health. 2011 Jan 12;11:30
pubmed: 21226919
N Engl J Med. 2008 Oct 9;359(15):1555-64
pubmed: 18799552
Emerg Infect Dis. 2006 Nov;12(11):1638-43
pubmed: 17283611
Med Mal Infect. 2016 Dec;46(8):424-428
pubmed: 27592517
Int J Environ Res Public Health. 2019 Mar 18;16(6):
pubmed: 30889780
Hum Vaccin Immunother. 2020 May 3;16(5):1093-1100
pubmed: 31725346